Senior insider sale
CHIEF FINANCIAL OFFICER at MIRUM PHARMACEUTICALS, INC. — senior position signals high conviction
$1.68M
16K shares
What this filing means
BJERKHOLT ERIC plans to sell 16K shares of MIRUM PHARMACEUTICALS, INC. valued at approximately $1.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2026ACC: 0001950047-26-007935
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
16K
Shares to sell
$1.68M
Approx. market value
6K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
1/23/2025
2.67KRestricted Stock
Not Applicable
9/11/2024
3.33KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Restricted Stock Not Applicable | 2.67K | — |
9/11/2024 | Restricted Stock Not Applicable | 3.33K | — |
| Total | 6K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5K
Market value
$611.3K
7/6/2026
—Completed
Units to sell
5K
Market value
$469.1K
6/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6K
Market value
$599.5K
8/11/2026
Total
Units
16K
Value
$1.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/6/2026 | 5K | $611.3K | — | Completed |
6/8/2026 | 5K | $469.1K | — | Completed |
| Planned — Approximate Date | ||||
8/11/2026 | 6K | $599.5K | NASDAQ | Planned |
| Total | 16K | $1.68M | ||